Czechia· CZ-0275701
KYSELINA ACETYLSALICYLOVÁ SANOFI
A acetylsalicylic acid product containing lysine acetylsalicylate, racemic, registered in Czechia by Sanofi s.r.o., Praha. The same ATC class is registered in 14 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Acetylsalicylic acid is registered in 14 of 19 countries.
Countries holding a registration under ATC B01AC06 (acetylsalicylic acid), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 9 of them publish a price we can compare per daily dose
Acetylsalicylic acid · ATC B01AC06
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- LYSINE ACETYLSALICYLATE, RACEMIC
- Manufacturer
- Sanofi s.r.o., Praha
- Country
- Czechia (CZ)
- ATC code
- B01AC06
- ATC class
- Acetylsalicylic acid
- Defined daily dose
- 1 Tablette, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- cz_kod_sukl02757016+6X5ML AMPCZK 2841
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
836 interactions on record for acetylsalicylic acid.
Graded by severity as the source publishes them — 55 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Acetylsalicylic acid · interactions on record
836 records
- 55 severe
- 246 moderate
- 39 minor
- 429 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- DalteparinB01AB04severe
- EnoxaparinB01AB05severe
67 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B01AC06
Acetylsalicylic acid, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e37e180b-7352-4526-aedc-f9701ec1b740 GET /v1/drugs/e37e180b-7352-4526-aedc-f9701ec1b740?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ PSO LQF",
"source": "sukl",
"strength": "0,5G",
"pack_size": "6+6X5ML AMP",
"substance": "LYSINE ACETYLSALICYLATE, RACEMIC",
"cz_kod_sukl": "0275701",
"product_type": "CH",
"substance_codes": "4151",
"registration_state": "B",
"registration_number": "16/078/02-C"
}See everything about acetylsalicylic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.